Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)
| Brand name | METFORMIN HYDROCHLORIDE EXTENDED RELEASE |
| Generic name | METFORMIN HYDROCHLORIDE |
| Active ingredient(s) | METFORMIN HYDROCHLORIDE |
| Distributed by / for | PD-Rx Pharmaceuticals, Inc. |
| NDC | 72789-009-30 |
| Full product label | metformin HCL ER 500 mg, a) 30 tablets NDC: 72789-009-30; b) 60 tablets NDC: 72789-009-60; c) 90 tablets NDC: 72789-009-90; d) 180 tablets NDC: 72789-009-93 bottles, Rx only, Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 |
| Recalling firm | PD-Rx Pharmaceuticals, Inc. |
| Distribution | AK, AZ, CA, CO, FL, GA, ID, IL, IN, KY, MN, NC, NY, OK, OR, WI |
| Quantity | 1683 bottles |
| Recall initiated | 2020-10-06 |
| Report date | 2020-11-11 |
| Recall completed | 2021-10-22 |
| Recall number | D-0059-2021 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Oklahoma City OK United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗